Modeling Host-Pathogen Interaction Using Lymphoid Organoids
- Conditions
- Staphylococcal Infections
- First Posted Date
- 2024-06-28
- Last Posted Date
- 2025-05-21
- Target Recruit Count
- 500
- Registration Number
- NCT06479837
- Locations
- 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States
🇺🇸National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Belatacept in Heart Transplantation
- Conditions
- Heart Transplant
- Interventions
- First Posted Date
- 2024-06-27
- Last Posted Date
- 2025-02-11
- Target Recruit Count
- 66
- Registration Number
- NCT06478017
- Locations
- 🇺🇸
Cedars Sinai Heart Institute/ Cedars Sinai Medical (Site # 71146), Los Angeles, California, United States
🇺🇸Tampa General Hospital (Site # 71150), Tampa, Florida, United States
🇺🇸NYU Langone Health (Site # 71177), New York, New York, United States
Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents
- First Posted Date
- 2024-06-27
- Last Posted Date
- 2025-03-14
- Target Recruit Count
- 30
- Registration Number
- NCT06477653
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
- Conditions
- Lung Transplant
- Interventions
- First Posted Date
- 2024-06-26
- Last Posted Date
- 2025-05-07
- Target Recruit Count
- 234
- Registration Number
- NCT06476132
- Locations
- 🇺🇸
University of California, Los Angeles (Site #: 71123), Los Angeles, California, United States
🇺🇸Johns Hopkins (Site #: 71119), Baltimore, Maryland, United States
🇺🇸Washington University (Site #: 71191), Saint Louis, Missouri, United States
Pregnancy Registry in Mali
- Conditions
- Pregnancy RelatedMalaria
- First Posted Date
- 2024-06-21
- Last Posted Date
- 2024-08-29
- Target Recruit Count
- 9500
- Registration Number
- NCT06468319
- Locations
- 🇲🇱
Kalifabougou MRTC Clinic, Kalifabougou, Région De Koulikoro, Mali
L9LS MAb in Malian Infants
- Conditions
- Malaria
- Interventions
- Biological: L9LSOther: Normal Saline
- First Posted Date
- 2024-06-14
- Last Posted Date
- 2024-08-28
- Target Recruit Count
- 180
- Registration Number
- NCT06461026
- Locations
- 🇲🇱
Torodo MRTC Clinic, Torodo, Région De Koulikoro, Mali
🇲🇱Faladje MRTC Clinic, Faladje, Région De Koulikoro, Mali
🇲🇱Kalifabougou MRTC Clinic, Kalifabougou, Région De Koulikoro, Mali
Phase 1, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of an Enterovirus D68-specific Monoclonal Antibody in Healthy Adults
- Conditions
- Enterovirus Infection
- Interventions
- Other: Placebo for EV68-228-N
- First Posted Date
- 2024-06-05
- Last Posted Date
- 2025-05-02
- Target Recruit Count
- 36
- Registration Number
- NCT06444048
- Locations
- 🇺🇸
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health, Baltimore, Maryland, United States
🇺🇸Vanderbilt University Medical Center, Nashville, Tennessee, United States
Safety and Immunogenicity Trial of MPV/S-2P SARS-CoV-2 Vaccine in Adults
- First Posted Date
- 2024-06-04
- Last Posted Date
- 2025-02-07
- Target Recruit Count
- 60
- Registration Number
- NCT06441968
- Locations
- 🇺🇸
The Hope Clinic of Emory University, Decatur, Georgia, United States
🇺🇸NYU Grossman Long Island School of Medicine - Vaccine Center, Mineola, New York, United States
🇺🇸Baylor College of Medicine, Houston, Texas, United States
Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study
- Conditions
- Macrophage Activation SyndromeHyperinflammatory SyndromesLymphohistiocytosis, HemophagocyticSecondary Hemophagocytic Lymphohistiocytosis
- First Posted Date
- 2024-04-01
- Last Posted Date
- 2025-05-06
- Target Recruit Count
- 200
- Registration Number
- NCT06339177
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
- Conditions
- HIV-1-infectionPregnancyPostpartum
- Interventions
- First Posted Date
- 2024-03-28
- Last Posted Date
- 2024-11-20
- Target Recruit Count
- 45
- Registration Number
- NCT06336434
- Locations
- 🇺🇸
Site 4601, University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program, La Jolla, California, United States
🇺🇸Site 5048, University of Southern California LA, Los Angeles, California, United States
🇺🇸Site 5013, Jacobi Medical Center Bronx, Bronx, New York, United States